Travere Therapeutics, Inc. · NASDAQ:TVTX
Dube Eric M sold 243,735 Travere Therapeutics, Inc. shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 19, 2026
On Oct 15, 2026, Dube Eric M (Director, CHIEF EXECUTIVE OFFICER) sold 243,735 Travere Therapeutics, Inc. shares at an average US$53.82 for US$13.1M under a trading plan, leaving 432,886 shares. Filed Oct 19, 2026 (Form 4).
- Sold
- 243,735 shares
- Price
- US$53.82 average (US$52.97 to US$55.02)
- Value
- US$13.1M
- Holding after
- 432,886 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | Option exercise | 43,735 | US$26.88 | 476,621 | Direct |
| Oct 15, 2026 | Common Stock | Option exercise | 200,000 | US$8.93 | 676,621 | Direct |
| Oct 15, 2026 | Common Stock | Sale | 128,065 | US$52.97 | 548,556 | Direct |
| Oct 15, 2026 | Common Stock | Sale | 37,270 | US$54.20 | 511,286 | Direct |
| Oct 15, 2026 | Common Stock | Sale | 78,400 | US$55.02 | 432,886 | Direct |
Source
Download original · View original at SEC
Related
- Travere Therapeutics, Inc.
- Dube Eric M
- Travere Therapeutics, Inc. shareholders
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Dube Eric M · May 6, 2026
- Form 4 · Dube Eric M · Apr 15, 2026
- Form 4 · Dube Eric M · Apr 2, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 12, 2026